de Souza, W. M., Lecuit, M. & Weaver, S. C. Chikungunya virus and other emerging arthritogenic alphaviruses. Nat. Rev. Microbiol. 23, 585–601 (2025).
Suhrbier, A., Jaffar-Bandjee, M. C. & Gasque, P. Arthritogenic alphaviruses—an overview. Nat. Rev. Rheumatol. 8, 420–429 (2012).
Bettis, A. A. et al. The global epidemiology of chikungunya from 1999 to 2020: a systematic literature review to inform the development and introduction of vaccines. PLoS Negl. Trop. Dis. 16, e0010069 (2022).
de Souza, W. M. et al. Chikungunya: a decade of burden in the Americas. Lancet Reg. Health Am. 30, 100673 (2024).
Morrison, T. E. Reemergence of chikungunya virus. J. Virol. 88, 11644–11647 (2014).
Ribeiro Dos Santos, G. et al. Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns. Nat. Med. 31, 2342–2349 (2025).
Silva, L. A. & Dermody, T. S. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J. Clin. Invest. 127, 737–749 (2017).
Simon, F., Javelle, E., Oliver, M., Leparc-Goffart, I. & Marimoutou, C. Chikungunya virus infection. Curr. Infect. Dis. Rep. 13, 218–228 (2011).
Chen, C. I. et al. Comparative pathogenesis of epidemic and enzootic chikungunya viruses in a pregnant rhesus macaque model. Am. J. Trop. Med. Hyg. 83, 1249–1258 (2010).
Messaoudi, I. et al. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity. PLoS Negl. Trop. Dis. 7, e2343 (2013).
Amaral, J. K., Taylor, P. C. & Schoen, R. T. Bone erosions and joint damage caused by chikungunya virus: a systematic review. Rev. Soc. Bras. Med. Trop. 57, e00404 (2024).
Chen, W. et al. Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J. Virol. 89, 581–593 (2015).
Labadie, K. et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest. 120, 894–906 (2010).
Hawman, D. W. et al. Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J. Virol. 87, 13878–13888 (2013).
Manimunda, S. P. et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans. R. Soc. Trop. Med. Hyg. 104, 392–399 (2010).
Schilte, C. et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl. Trop. Dis. 7, e2137 (2013).
Kang, H. et al. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. Lancet Infect. Dis. 24, 488–503 (2024).
Sissoko, D. et al. Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3, e389 (2009).
Miner, J. J. et al. Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 67, 1214–1220 (2015).
Amaral, J. K., Bilsborrow, J. B. & Schoen, R. T. Chronic chikungunya arthritis and rheumatoid arthritis: what they have in common. Am. J. Med. 133, e91 (2020).
Curtis, J. R. et al. A comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registries. Semin. Arthritis Rheum. 40, 2–14.e11 (2010).
McCarthy, M. K., Davenport, B. J. J. & Morrison, T. E. Chronic chikungunya virus disease. Curr. Top. Microbiol. Immunol. 435, 55–80 (2019).
Courvoisier, D. S. et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. Rheumatology 60, 820–828 (2021).
Bouquillard, É & Combe, B. A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years. Joint Bone Spine 76, 654–657 (2009).
Bouquillard, E. et al. Rheumatic manifestations associated with chikungunya virus infection: a study of 307 patients with 32-month follow-up (RHUMATOCHIK study). Joint Bone Spine 85, 207–210 (2018).
McCarthy, M. K. & Morrison, T. E. Persistent RNA virus infections: do PAMPS drive chronic disease?. Curr. Opin. Virol. 23, 8–15 (2017).
Hoarau, J. J. et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184, 5914–5927 (2010).
Ozden, S. et al. Human muscle satellite cells as targets of chikungunya virus infection. PLoS ONE 2, e527 (2007).
Chang, A. Y. et al. Chikungunya arthritis mechanisms in the Americas: a cross-sectional analysis of chikungunya arthritis patients twenty-two months after infection demonstrating no detectable viral persistence in synovial fluid. Arthritis Rheumatol. 70, 585–593 (2018).
Weber, W. C. et al. Development of a virulent O’nyong’nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine. PLoS Negl. Trop. Dis. 19, e0012938 (2025).
Morrison, T. E. et al. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am. J. Pathol. 178, 32–40 (2011).
Stoermer, K. A. et al. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J. Immunol. 189, 4047–4059 (2012).
Miner, J. J. et al. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis. Sci. Transl. Med. 9, eaah3438 (2017).
Wilson, J. A. et al. RNA-seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation. PLoS Pathog. 13, e1006155 (2017).
Hawman, D. W. et al. Pathogenic chikungunya virus evades B cell responses to establish persistence. Cell Rep. 16, 1326–1338 (2016).
Poo, Y. S. et al. Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. PLoS Negl. Trop. Dis. 8, e3354 (2014).
Young, A. R. et al. Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA. PLoS Pathog. 15, e1007993 (2019).
Dunagan, M. M. et al. Interaction of the endogenous antibody response with activating FcgammaRs enhance control of Mayaro virus through monocytes. PLoS Pathog. 21, e1012944 (2025).
Gardner, J. et al. Chikungunya virus arthritis in adult wild-type mice. J. Virol. 84, 8021–8032 (2010).
Chen, W. et al. Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation. Nat. Microbiol 2, 1435–1445 (2017).
Lum, F. M. et al. Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya. EMBO Mol. Med. 16, 641–663 (2024).
Wolf, S. et al. Inhibition of interleukin-1β signaling by anakinra demonstrates a critical role of bone loss in experimental arthritogenic alphavirus infections. Arthritis Rheumatol. 71, 1185–1190 (2019).
Franchi, L., Eigenbrod, T., Munoz-Planillo, R. & Nunez, G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10, 241–247 (2009).
van den Berg, W. B. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin. Arthritis Rheum. 30, 7–16 (2001).
Udalova, I. A., Mantovani, A. & Feldmann, M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat. Rev. Rheumatol. 12, 472–485 (2016).
Davenport, B. J. et al. Chikungunya virus evades antiviral CD8+ T cell responses to establish persistent infection in joint-associated tissues. J. Virol. 94, e02036-19 (2020).
Ware, B. C., Parks, M. G., da Silva, M. O. L. & Morrison, T. E. Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2. PLoS Pathog. 20, e1011794 (2024).
Goh, L. Y. H. et al. Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications. J. Gen. Virol. 96, 507–512 (2015).
Teo, T. H. et al. A pathogenic role for CD4+ T cells during chikungunya virus infection in mice. J. Immunol. 190, 259–269 (2013).
Linn, M. L., Aaskov, J. G. & Suhrbier, A. Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J. Gen. Virol. 77, 407–411 (1996).
Way, S. J., Lidbury, B. A. & Banyer, J. L. Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology 301, 281–292 (2002).
Linn, M. L., Mateo, L., Gardner, J. & Suhrbier, A. Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J. Virol. 72, 5146–5153 (1998).
Misharin, V. et al. Nonclassical Ly6C− monocytes drive the development of inflammatory arthritis in mice. Cell Rep. 9, 591–604 (2014).
Culemann, S. et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature 572, 670–675 (2019).
De Leon-Oliva, D. et al. AIF1: function and connection with inflammatory diseases. Biology 12, 694 (2023).
Gavin, A. L. et al. PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. Nat. Immunol. 19, 942–953 (2018).
Simmons, D. P. et al. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci. Immunol. 7, eabf2846 (2022).
Fisher, J. et al. Orientia tsutsugamushi selectively stimulates the C-type lectin receptor Mincle and type 1-skewed proinflammatory immune responses. PLoS Pathog. 17, e1009782 (2021).
Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185–194 (2007).
Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95, 15623–15628 (1998).
Heink, S., Ludwig, D., Kloetzel, P. M. & Kruger, E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl Acad. Sci. USA 102, 9241–9246 (2005).
Steimle, V., Siegrist, C. A., Mottet, A., Lisowska-Grospierre, B. & Mach, B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265, 106–109 (1994).
Kiritsy, M. C. et al. A genetic screen in macrophages identifies new regulators of IFNγ-inducible MHCII that contribute to T cell activation. eLife 10, e65110 (2021).
Gois, B. M. et al. Regulatory T cells in acute and chronic human chikungunya infection. Microbes Infect. 24, 104927 (2022).
Lee, W. W. L. et al. Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice. J. Virol. 89, 7893–7904 (2015).
Agarwal, R. et al. Chikungunya virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans. Cell Rep. Med. 6, 102134 (2025).
McCarthy, M. K. et al. Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment. JCI Insight 3, e121100 (2018).
Teo, T. H. et al. Fingolimod treatment abrogates chikungunya virus-induced arthralgia. Sci. Transl. Med. 9, eaal1333 (2017).
Toribio-Fernandez, R. et al. Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major. Cell Death Dis. 9, 9 (2018).
Chujor, C. S. N., Klein, L. & Lam, C. Selective inhibition of interleukin-1β gene expression in activated RAW 264.7 macrophages by interferon-γ. Eur. J. Immunol. 26, 1253–1259 (1996).
Masters, S. L. et al. Regulation of interleukin-1β by interferon-γ is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep. 11, 640–646 (2010).
Yin, P. et al. Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo. Nat. Microbiol 8, 1653–1667 (2023).
Nakaya, H. I. et al. Gene profiling of chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum. 64, 3553–3563 (2012).
Soden, M. et al. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 43, 365–369 (2000).
Soares-Schanoski, A. et al. Systems analysis of subjects acutely infected with the chikungunya virus. PLoS Pathog. 15, e1007880 (2019).
de Castro-Jorge, L. A. et al. The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus. PLoS Pathog. 15, e1007934 (2019).
Fragkoudis, R., Dixon-Ballany, C. M., Zagrajek, A. K., Kedzierski, L. & Fazakerley, J. K. Following acute encephalitis, Semliki Forest virus is undetectable in the brain by infectivity assays but functional virus RNA capable of generating infectious virus persists for life. Viruses 10, 273 (2018).
Levine, B. & Griffin, D. E. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J. Virol. 66, 6429–6435 (1992).
Sawicki, D. L., Silverman, R. H., Williams, B. R. & Sawicki, S. G. Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R. J. Virol. 77, 1801–1811 (2003).
Remenyi, R. et al. Persistent replication of a chikungunya virus replicon in human cells is associated with presence of stable cytoplasmic granules containing nonstructural protein 3. J. Virol. 92, e00477-18 (2018).
Utt, A. et al. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2. J. Virol. 89, 3145–3162 (2015).
Frolov, I. et al. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J. Virol. 73, 3854–3865 (1999).
Lentscher, A. J. et al. Chikungunya virus replication in skeletal muscle cells is required for disease development. J. Clin. Invest. 130, 1466–1478 (2020).
Rohatgi, A. et al. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. J. Virol. 88, 2414–2425 (2014).
Bullock, C. B. et al. Type I interferon signaling in dendritic cells limits direct antigen presentation and CD8+ T cell responses against an arthritogenic alphavirus. mBio 15, e0293024 (2024).
Carpentier, K. S. et al. MARCO+ lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination. EMBO J. 40, e108966 (2021).
Holmes, A. C. et al. Ly6C+ monocytes in the skin promote systemic alphavirus dissemination. Cell Rep. 43, 113876 (2024).
Li, F. S. et al. Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia. Cell Rep. 42, 112418 (2023).
McCarthy, M. K. et al. MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2. PLoS Pathog. 16, e1008292 (2020).
Lucas, C. J. et al. Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO. JCI Insight 9, e176537 (2024).
Fu, R. et al. clustifyr: an R package for automated single-cell RNA sequencing cluster classification. F1000Research 9, 223 (2020).
Malhotra, D. et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 13, 499–510 (2012).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
Phipson, B. et al. Propeller: testing for differences in cell type proportions in single cell data. Bioinformatics 38, 4720–4726 (2022).
Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101–1108 (2008).
Greninger, A. L. et al. Rapid metagenomic next-generation sequencing during an investigation of hospital-acquired human parainfluenza virus 3 infections. J. Clin. Microbiol. 55, 177–182 (2017).
Dries, R. et al. Giotto: a toolbox for integrative analysis and visualization of spatial expression data. Genome Biol. 22, 78 (2021).
Sheridan, R. rnabioco/morrison-chronic-chikv: v0.2.0. Zenodo https://doi.org/10.5281/zenodo.18499811 (2026).
Sheridan, R. rnabioco/morrison-chronic-chikv-xenium: v0.2.0. Zenodo https://doi.org/10.5281/zenodo.18499816 (2026).